Hesperidin methylchalcone

CAS No. 24292-52-2

Hesperidin methylchalcone( —— )

Catalog No. M21239 CAS No. 24292-52-2

Hesperidin methylchalcone is the Citrus original products with powerful antioxidant activity. It can suppresse experimental gout arthritis in mice by inhibiting NF-κB activation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 91 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Hesperidin methylchalcone
  • Note
    Research use only, not for human use.
  • Brief Description
    Hesperidin methylchalcone is the Citrus original products with powerful antioxidant activity. It can suppresse experimental gout arthritis in mice by inhibiting NF-κB activation.
  • Description
    Hesperidin methylchalcone is the Citrus original products with powerful antioxidant activity. It can suppresse experimental gout arthritis in mice by inhibiting NF-κB activation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    NF-κB
  • Recptor
    NF-κB
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    24292-52-2
  • Formula Weight
    624.6
  • Molecular Formula
    C29H36O15
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:1 mg/mL (16.1 mM)
  • SMILES
    C[C@@H]([C@@H]([C@H]([C@H]1O)O)O)O[C@H]1OC[C@H]([C@H]([C@@H]([C@H]1O)O)O)O[C@H]1Oc1cc(OC)c(C(/C=C/c(cc2)cc(O)c2OC)=O)c(O)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ruiz-Miyazawa K W Almeida P R F Borghi S M et al. Hesperidin methylchalcone suppresses experimental gout arthritis in mice by inhibiting NF-kB activation[J]. Journal of Agricultural & Food Chemistry 2018:acs.jafc.8b00959-.
molnova catalog
related products
  • euphorbiafactor L2

    Euphorbiafactor?L2?alleviates lipopolysaccharide-induced acute lung injury and inflammation through inhibits NF-κB activation.

  • BML-190

    BML-190 is a specific CB2 receptor inverse agonist (Ki: 435 nM), with 50-fold selectivity over CB1 receptor.

  • IT-901

    IT-901 is a novel potent, small molecule inhibitor of NF-κB subunit c-Rel.